The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments

Blood

Volumn 98, Issue 3, 2001, Pages 851-859

  Mansfield, Elizabeth ^a,b   Chae, Jae Jin ^a,b   Komarow, Hirsh D ^a,b   Brotz, Tilmann M ^a,b   Frucht, David M ^a,b   Aksentijevich, Ivona ^a,b   Kastner, Daniel L ^a,b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL PROTEIN; COLCHICINE; GENE PRODUCT; GLUCOCORTICOID; GREEN FLUORESCENT PROTEIN; PACLITAXEL; PHALLOIDIN; PYRIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; AMINO TERMINAL SEQUENCE; ARTICLE; CELL STRAIN COS7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DISEASE ASSOCIATION; FAMILIAL MEDITERRANEAN FEVER; FLUORESCENCE MICROSCOPY; FMF GENE; GENE DELETION; GENE MUTATION; GOLGI COMPLEX; GRANULOCYTE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEFV GENE; MICROTUBULE ASSEMBLY; MOLECULAR CLONING; MOLECULAR INTERACTION; MOLECULAR STABILITY; MONOCYTE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

EID: 0035437141     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.3.851     Document Type: Article

References (68)

1. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797-807.
2. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25-31.
3. Centola M, Wood G, Frucht DM, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000;95:3223-3231.
4. Matzner Y, Abedat S, Shapiro E, et al. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures. Blood. 2000;96:727-731.
5. Chae JJ, Centola M, Aksentijevich I, et al. Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial mediterranean fever. Mamm Genome. 2000;11:428-435.
6. Bar-Eli M, Ehrenfeld M, Levy M, Gallily R, Eliakim M. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci. 1981;281:15-18.
7. Disdier P, Fossat C, Veit V, et al. Hyperactive polymorphonuclear leucocytes migration in patients with familial Mediterranean fever. Clin Rheumatol. 1996;15:517-518.
8. Bar-Eli M, Territo MA, Peters RS, Schwabe AD. A neutrophil lysozyme leak in patients with familial Mediterranean fever. Am J Hematol. 1981;11:387-395.
9. Anton PA, Targan SR, Vigna SR, Durham M, Schwabe AD, Shanahan F. Enhanced neutrophil chemiluminescence in familial Mediterranean fever. J Clin Immunol. 1988;8:148-156.
10. Courillon-Mallet A, Bevilacqua M, Wautier JL, Dervichian M, Cattan D, Caen J. Increased procoagulant response of monocytes from patients with familial Mediterranean fever. Thromb Haemost. 1986;56:211-213.
11. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med. 1974;291:932-934.
12. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Ailing DW. Colchicine therapy for familial Mediterranean fever: a controlled, double-blind study. N Engl J Med. 1974;291:934-937.
13. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001-1005.
14. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227-253.
15. Margolis RL, Wilson L. Addition of colchicinetubulin complex to microtubule ends: the mechanism of substoichiometric colchicine poisoning. Proc Natl Acad Sci U S A. 1977;74:3466-3470.
16. Wilson L, Farrell KW. Kinetics and steady state dynamics of tubulin addition and loss at opposite microtubule ends: the mechanism of action of colchicine. Ann N Y Acad Sci. 1986;466:690-708.
17. Skoufias D, Wilson L. Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. Biochemistry. 1992;31:738-746.
18. Liao G, Nagasaki N, Gundersen GG. Low concentrations of nocodazole interfere with fibroblast locomotion without significantly affecting microtubule level: implications for the role of dynamic microtubules in cell locomotion. J Cell Sci. 1995;108:3473-3483.
19. Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest. 1995;96:994-1002.
20. Bochner BS, Rutledge BK, Schleimer RP. Interleukin 1 production by human lung tissue, II: inhibition by anti-inflammatory steroids. J Immunol. 1987;139:2303-2307.
21. Beutler B, Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. Ann Rev Immunol. 1989;7:625-655.
22. Didonato JA, Saatcioglu F, Karin M. Molecular mechanisms of immunosuppression and antiinflammatory activities by glucocorticoids. Am J Respir Crit Care Med. 1996;154:S11-S15.
23. O'Leary EC, Marder P, Zuckerman SH. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin expression and inflammatory mediators. Am J Respir Cell Mol Biol. 1996;15:97-106.
24. Jilma B, Voltmann J, Albinni S, et al. Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans. Clin Pharmacol Ther. 1997;62:562-568.
25. Nakagawa M, Bondy GP, Waisman D, Minshall D, Hogg JC, van Eeden SF. The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. Blood. 1999;93:2730-2737.
26. Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell. 2000;5:831-840.
27. Centola M, Aksentijevich I, Kastner DL. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet. 1998;7:1581-1588.
28. Papin S, Duquesnoy P, Cazeneuve C, et al. Alternative splicing at the MEFVlocus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus. Hum Mol Genet. 2000;9:3001-3009.
29. Meroni G, Reymond A, Fantozzi A, et al. Functional genomics of the B-box gene family reveals a possible role in subcellular compartmentalization [abstract]. Am J Hum Genet. 1999;65:A80.
30. Jack LJ, Mather IH. Cloning and analysis of cDNA encoding bovine butyrophilin, an apical glycoprotein expressed in mammary tissue and secreted in association with the milk-fat globule membrane during lactation. J Biol Chem. 1990;265:14481-14486.
31. Ye TZ, Gordon CT, Lai YH, et al. Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein. Gene. 2000;242:337-345.
32. Ghadessy FJ, Chen D, Kini RM, et al. Stonustoxin is a novel lethal factor from stonefish (Synanceja horrida) venom: cDNA cloning and characterization. J Biol Chem. 1996;271:25575-25581.
33. Schweiger S, Foerster J, Lehmann T, et al. The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci U S A. 1999;96:2794-2799.
34. Cainarca S, Messali S, Ballabio A, Meroni G. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. Hum Mol Genet. 1999;8:1387-1396.
35. Tidow N, Chen X, Muller C, et al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood. 2000;95:1451-1455.
36. Chen X, Bykhovskaya Y, Tidow N, et al. The familial Mediterranean fever protein interacts and colocalizes with a putative Golgi transporter. Proc Soc Exp Biol Med. 2000;224:32-40.
37. Roobol A, Sahyoun ZP, Carden MJ. Selected subunits of the cytosolic chaperonin associate with microtubules assembled in vitro. J Biol Chem. 1999;274:2408-2415.
38. Griffith KJ, Chan EK, Lung CC, et al. Molecular cloning of a novel 97-kd Golgi complex autoantigen associated with Sjogren's syndrome. Arthritis Rheum. 1997;40:1693-1702.
39. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 1989;56:801-813.
40. Matzner Y, Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med. 1984;311:287-290.
41. Ayesh SK, Azar Y, Barghouti II, Ruedi JM, Babior BM, Matzner Y. Purification and characterization of a C5a-inactivating enzyme from human peritoneal fluid. Blood. 1995;85:3503-3509.
42. Walter DM, Paul KS, Waters MG. Purification and characterization of a novel 13 S hetero-oligomeric protein complex that stimulates in vitro Golgi transport. J Biol Chem. 1998;273:29565-29576.
43. Presley JF, Smith C, Hirschberg K, et al. Golgi membrane dynamics. Mol Biol Cell. 1998;9:1617-1626.
44. Bailly M, Macaluso F, Cammer M, Chan A, Segall JE, Condeelis JS. Relationship between Arp2/3 complex and the barbed ends of actin filaments at the leading edge of carcinoma cells after epidermal growth factor stimulation. J Cell Biol. 1999;145:331-345.
45. Alonso AC, Grundke-Iqbal I, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med. 1996;2:783-787.
46. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science. 1998;282:1914-1917.
47. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702-705.
48. Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 1999;23:257-271.
49. Quaderi NA, Schweiger S, Gaudenz K, et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet. 1997;17:285-291.
50. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635-644.
51. Blanchoin L, Amann KJ, Higgs HN, Marchand JB, Kaiser DA, Pollard TD. Direct observation of dendritic actin filament networks nucleated by Arp2/3 complex and WASP/Scar proteins. Nature. 2000;404:1007-1011.
52. Tian L, Nelson DL, Stewart DM. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J Biol Chem. 2000;275:7854-7861.
53. Keller HU, Naef A, Zimmermann A. Effects of colchicine, vinblastine and nocodazole on polarity, motility, chemotaxis and cAMP levels of human polymorphonuclear leukocytes. Exp Cell Res. 1984;153:173-185.
54. Blocker A, Severin FF, Burkhardt JK, et al. Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol. 1997;137:113-129.
55. Blocker A, Griffiths G, Olivo JC, Hyman AA, Severin FF. A role for microtubule dynamics in phagosome movement. J Cell Sci. 1998;111:303-312.
56. Mollinedo F, Nieto JM, Andreu JM. Cytoplasmic microtubules in human neutrophil degranulation: reversible inhibition by the colchicine analogue 2-methoxy-5-(2′,3′,4′- trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one. Mol Pharmacol. 1989;36:547-555.
57. Jackson JK, Tudan C, Sahl B, Pelech SL, Burt HM. Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol. Immunology. 1997;90:502-510.
58. Gundersen GG, Cook TA. Microtubules and signal transduction. Curr Opin Cell Biol. 1999;11:81-94.
59. Waterman-Storer CM, Worthylake RA, Liu BP, Burridge K, Salmon ED. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat Cell Biol. 1999;1:45-50.
60. Linder S, Nelson D, Weiss M, Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A. 1999;96:9648-9653.
61. Malawista SE. The action of colchicine in acute gouty arthritis. Arthritis Rheum. 1975;18:835-846.
62. Roberge CJ, Gaudry M, de Medicis R, Lussier A, Poubelle PE, Naccache PH. Crystal-induced neutrophil activation, IV: specific inhibition of tyrosine phosphorylation by colchicine. J Clin Invest. 1993;92:1722-1729.
63. Masumoto J, Taniguchi S, Sagara J. Pyrin N-terminal homology domain- and caspase recruitment domain-dependent oligomerization of ASC. Biochem Biophys Res Commun. 2001;280:652-655.
64. Bertin J, DiStefano PS. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 2000;7:1273-1274.
65. Martinon F, Hoffman K, Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol. 2001;10:R118-R120.
66. Hlaing T, Guo RF, Dilley KA, et al. Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J Biol Chem. 2001;276:9230-9238.
67. Tuņa M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN. Acute phase response and evolution of familial Mediterranean fever [letter]. Lancet. 1999;353:1415.
68. Booth DR, Gillmore JD, Lachmann HJ, et al. The genetic basis of autosomal dominant familial Mediterranean fever. Q J Med. 2000;93:217-221.